Evidence map›Paper›PMID 28993694›Full record

ArticleScientific reports2017

Quantifying the relative immune cell activation from whole tissue/organ-derived differentially expressed gene data.

Edward Wijaya, Yoshinobu Igarashi, Noriyuki Nakatsu, Yasunari Haseda, Joel Billaud, Yi-An Chen, Kenji Mizuguchi, Hiroshi Yamada, Ken Ishii, Taiki Aoshi

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Host Immune Response to Clinical HypervirulentJournal of immunology research · 2022
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Edward WijayaSystem Immunology Laboratory, Immunology Frontier Research Centre, Osaka University, Osaka, 565-0781, Japan.
Yoshinobu IgarashiToxicogenomics-Informatics Project, National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, 567-0085, Japan.
Noriyuki NakatsuToxicogenomics-Informatics Project, National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, 567-0085, Japan.
Yasunari HasedaVaccine Dynamics Project, BIKEN Innovative Vaccine Research Alliance Laboratories, Osaka University, Osaka, 565-0871, Japan.
Joel BillaudSystem Immunology Laboratory, Immunology Frontier Research Centre, Osaka University, Osaka, 565-0781, Japan.
Yi-An ChenBioinformatics Project, National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, 567-0085, Japan.
Kenji MizuguchiBioinformatics Project, National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, 567-0085, Japan.ORCID 0000-0003-3021-7078
Hiroshi YamadaToxicogenomics-Informatics Project, National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, 567-0085, Japan.
Ken IshiiVaccine Science Laboratory, Immunology Frontier Research Centre, Osaka University, Osaka, 565-0781, Japan.ORCID 0000-0002-6728-3872
Taiki AoshiVaccine Dynamics Project, BIKEN Innovative Vaccine Research Alliance Laboratories, Osaka University, Osaka, 565-0871, Japan. aoshi@biken.osaka-u.ac.jp.
National Institute of Biomedical Innovation, Health and Nutrition · JPInstitut de Recherche Vaccinale · FRThe University of Osaka · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Evaluation of immune responses in individual immune cell types is important for the development of new medicines. Here, we propose a computational method designated ICEPOP (Immune CEll POPulation) to estimate individual immune cell type responses from bulk tissue and organ samples. The relative gene responses are scored for each cell type by using the data from differentially expressed genes derived from control- vs drug-treated sample pairs, and the data from public databases including ImmGen and IRIS, which contain gene expression profiles of a variety of immune cells. By ICEPOP, we analysed cell responses induced by vaccine-adjuvants in the mouse spleen, and extended the analyses to human peripheral blood mononuclear cells and gut biopsy samples focusing on human papilloma virus vaccination and inflammatory bowel disease treatment with Infliximab. In both mouse and human datasets, our method reliably quantified the responding immune cell types and provided insightful information, demonstrating that our method is useful to evaluate immune responses from bulk sample-derived gene expression data. ICEPOP is available as an interactive web site ( https://vdynamics.shinyapps.io/icepop/ ) and Python package ( https://github.com/ewijaya/icepop ).

Indexed as

TranscriptomeAnimalsBiopsyDatabases, GeneticDNA ContaminationGastrointestinal TractHuman papillomavirus 16HumansInflammatory Bowel DiseasesInfliximabLeukocytes, MononuclearMiceOrgan SpecificitySoftwareSpleenVirionInfliximab

Identifiers

PMID28993694
PMCPMC5634445
OpenAlexW2763318931

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.